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Abstract Immunobiological study is a key to revealing the important basis of facial nerve repair and
regeneration for both research and development of clinic treatments. The microenvironmental changes around an
injuried facial motoneuron, i.e., the aggregation and expression of various types of immune cells and molecules in
a dynamic equilibrium, impenetrate from the start to the end of the repair of an injured facial nerve. The concept of
"immune microenvironment for facial nerve repair and regeneration", mainly concerns with the dynamic exchange
between expression and regulation networks and a variaty of immune cells and immune molecules in the process
of facial nerve repair and regeneration for the maintenance of a immune microenvironment favorable for nerve
repair. Investigation on microglial activation and recruitment, T cell behavior, cytokine networks, and
immunological cellular and molecular signaling pathways in facial nerve repair and regeneration are the current
hot spots in the research on immunobiology of facial nerve injury. The current paper provides a comprehensive
review of the above mentioned issues. Research of these issues will eventually make immunological interventions
practicable treatments for facial nerve injury in the clinic.
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Introduction
The neuronal response to injury, which includes
immune involvement, has a dual nature. On the one
hand, the inflammatory response exhibits features
similar to those in other body tissues, namely,
involvement of tissue remodeling. On the other hand, it
behaves very differently because of the specialized
nature of the neuronal tissue[1]. The neuronal repair
program and the immune surveillance response are two
of the key modules regulating cellular changes in the
injured brain. Both modules probably contain different
subsets controlled by specific molecular mechanisms.
At present, neuritis and demyelization are
generally acknowledged as common and
pathophysiological bases of peripheral facial paralysis
(Bell's paralysis, traumatic, infectious and others) by
scholars worldwide. Cellular immune response and
humoral immune response play a key role in the
outbreak and development of peripheral facial
paralysis. The time course and morphology of
microglial activation suggest that proregenerative and
neuroprotective functions are carried out by microglia.
Cytokine network plays a vital role in the regulation of
repair and regeneration of facial nerve by up- and
down-regulating various parameters of immune
function. Additionally, as central regulatory cells of the
immune system, T cells mediate many of their
functions via the secretion of cytokines. Moreover, a
series of transcription factors, cell death signaling
pathways, cell adhesion molecules signaling
recognition, and other cellular and molecular events
have been investigated extensively for their roles in the
repair and regeneration of facial nerve.
In summary, multiple aspects of cross talks
between the immune and the nervous systems are
involved after neuronal injury ［2］. Immunobiological
study is a key to discover the basis of facial nerve
repair and regeneration. The focus in this review is on
microglial activation and recruitment, T cell behavior,
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the role of cytokine networks and immunological
cellular and molecular signaling pathways in facial
nerve repair and regeneration, in an attempt to provide
essential information for transition of facial nerve
research from the laboratory to the clinic.
Microglial activation and recruitment
Microglia: more than the APC
Studies have suggested that macrophages and/or
dendritic cells may act as the antigen presenting cell
(APC) in nerve injury. Another type of cells, e.g.,
microglia, are also capable of acting as an APC. It has
been shown that, after facial nerve transection,
microglia become activated and upregulate both major
histocompability complex 2(MHC II) and B7-2
(required for a cell to be classified as an APC).
Additionally, it has been shown that T cells are present
in the facial nucleus after facial nerve transection[3, 4］.
Taken together, these data suggest that microglia,
rather than a peripheral APC, may play a critical role in
antigen presentation after nerve injury.
Microglial activation in the facial nucleus is
triggered within hours after the injury, and increased
numbers of activated microglia remain in the area for
at least 2 weeks, at which time some axons have
already reinnervated their targets. The time course and
morphology of microglial activation suggest that
proregenerative and neuroprotective functions are
carried out by microglia. Perineuronal ensheathment of
neurons by microglia accomplishes at least two
neuroprotective actions: removal of excitatory input
through displaced afferent synapses, and increase of
physical proximity of axotomized neurons to
microglial cells, which may facilitate targeted delivery
of growth factors from activated microglia to injured
neurons.
Effects of immune surveillance with microglial
activation and recruitment
Microglial activation is among the first cellular
changes in almost all forms of brain pathology. Kalla[5]
studied microglial activation and recruitment in repair
and regeneration of facial nerve in a mouse model with
macrophage colony-stimulating factor (MCSF)
deficiency. This MCSF deficiency in the homozygous,
osteopetrotic mice（op/op mice） interfered strongly
with the early stages of microglial activation and
proliferation and their spreading on the surface of
injured but surviving facial motoneurons. These
changes were accompanied by a clear reduction in the
recruitment of T-cells during the first phase of
lymphocyte infiltration into the axotomized facial
motor nucleus within the first 24 hours after injury. In
contrast, there were no apparent effects on the speed of
axonal regeneration or neuronal survival. Astrocyte
response and synaptic stripping were not affected.
Delayed neuronal cell death also led to a normal
microglial and lymphocyte response, with the
formation of phagocytotic microglial nodules and a
strong recruitment of T-cells to these breakdown sites
of neuronal debris.
In the context of immune surveillance in the
injured brain, this may lead to inactivation or
disappearance of T-cells that recognize self-antigens on
the surface of the bystander-activated microglial cells.
In addition to the direct effects by MCSF on MCSF
receptor-positive cells, MCSF deficiency in the op/op
mice is also accompanied by a strong reduction in the
recruitment of T-lymphocytes during the first phase of
lymphocyte infiltration. The lack of MCSF receptors
on T-cells themselves clearly points to a key role for
the activated microglial cells in this early phase of
immune surveillance[5].
Activated microglial cells are a rich source of
molecules that enhance or inhibit neuronal survival,
regeneration, and other aspects of neural repair. The
injury-mediated production of NO, interleukin-1 (IL1),
reactive oxygen radicals, proteolytic enzymes, or
excitotoxic substances may all contribute to the
pathology in the injured brain and enhance secondary
damage[6, 7]. Stimulated microglia also synthesize
neurotrophic molecules such as nerve growth
factor(NGF), transfoming growth factor-β1(TGF-β1),
and thrombospondin (TSP). Some microglial
molecules may also act as a double-edged sword,
depending on the active concentration and the
pathological condition.
The two modules: neuronal repair program and
immune surveillance
Microglial cells are activated very rapidly, and
they proliferate, adhere to damaged cellular structures,
such as injured neurons, and spread on their surface.
The up-regulation of the antigen-presenting molecules
(MHC1) and co-stimulatory factors and the recruitment
of T-cells all point to the microglia playing a pivotal
role in the immune surveillance of the injured brain[8].
MCSF deficiency interferes with early microglial
activation. These data suggest that the cellular reaction
to neural injury is organized into several separate sets
of effects, or response modules, and there may be little
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cross-talk between the different sets. In this concept,
the neuronal repair program and the immune
surveillance response are two of the key modules
regulating cellular changes in the injured brain. Both of
these modules probably contain different subsets
controlled by specific molecular mechanisms. At
present, little is known about the neuronal triggers that
initiate these different cellular responses. The induction
of transcription factors such as c-jun, junD, and STAT3
and their subsequent phosphorylation and translocation
to the nucleus are very early events in the neuronal
response to injury [9].
Neural injury induces a highly elaborate response
from a variety of cells both in the peripheral and in the
central parts of the nervous system. Understanding the
overall organization, the hierarchy, and the molecular
mechanisms involved in this response is clearly critical
in designing strategies to reduce secondary damage
and to improve repair in the damaged brain. Moreover,
selective defects in the activation of particular cell
types, such as the defective early activation in the op/
op microglia, provide a particularly instructive lesson
about the contribution of this cell type to the overall
response as well as its organization on the molecular
level. The absence of MCSF severely impaires the
early phases of microglial activation. It does not affect
axonal regeneration, synaptic stripping, neuronal
survival, or cellular response of the neighboring
astrocytes[5]. However, it reduces the early recruitment
of lymphocytes into the axotomized facial motor
nucleus, suggesting that this cytokine plays a key role
in the initiation of inflammatory changes in the brain
and in the interaction with the immune system.
T cell behavior in facial nerve research
T cell activation in repair and regeneration of facial
nerve
T cell activation is a result of complicated action
between multiple ligand-receptors, which is offered by
T cells and antigen, including the formation of
immunological synapse (IS). The interactivity
integration triggers the biochemistry events of inner T
cells that lead to cell immune responses. Such effects
as acceleration or inhibition on activation,
proliferation, differentiation and domino effects are
processed through cell factors secretion and cell-cell
contact. T cell activation plays a key role in both
normal and pathology immunity responses. The degree
and direction of immunity responses are determined by
the degree and direction of activated T cells[10].
In the mouse facial nerve axotomy model, T cells
infiltrated the central nervous system (CNS ) through
an intact blood-brain barrier (BBB) and homed to
affected motoneurons[11]. T lymphocytes appear to
confer neuroprotection upon a selective population of
facial motoneurons, as severe combined
immunodeficient (SCID) mice, which lack mature T
and B cells, show decreased neuronal survival
following nerve injury when compared to wild-types[12].
Adoptive transfer of functional T cells into SCID mice
restores the neuroregenerative capacity of these
animals to the levels of wild-type mice[13,14].
Interactions between T cells and microglia may be
critical in mediating neuroimmunological processes
associated with neuronal regeneration in mice[11, 15].
Evidence suggests that infiltrating T cells may, in part,
modulate levels of microglial reactivity induced by
facial nerve axotomy.
There are strain-dependent differences in T cell
infiltration and microglial reactivity. Moreover,
microglial responsiveness in the axotomized facial
motoneuron (FMN) appears to be regulated
independent of the peripheral immune response[14].
These data suggest that (1) T cells do not appear to
modify measures of microglial reactivity in the
axotomized FMN; and (2) the impact of T cell
processes on injured motoneurons in immunologically
intact and in immunodeficient mice grafted with T
cells by adoptive transfer may be different.
T cell subsets and facial motoneurons
Cells of the acquired immune system, specifically
T lymphocytes have been considered detrimental
during a neurological injury and/or disease state. For
example, the demylinating disease multiple sclerosis is
thought to be mediated by both CD4 + and CD8 + T
lymphocytes[16]. Serpe's findings suggest that cells of
the acquired immune system play a beneficial role in
both neuronal survival and nerve regeneration after
peripheral nerve injury. The results establish that CD4+
T lymphocytes, but not CD8+ T lymphocytes or B cells,
mediate FMN survival after peripheral nerve injury.
Additionally, natural killer(NK) cells have been ruled
out as playing a role in mediating FMN survival after
injury[13, 17]. Additionally, recent data that supports a
positive role for T lymphocytes after injury, have
demonstrated that self-reactive T cells are beneficial
following spinal cord injury and/or optic nerve
injury [18-20].
Facial nerve injury triggers both a peripheral
response at the site of injury and a central response in
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the area that includes the cell body and surrounding
glia. Thus, there are multiple sites and populations of
APC that could potentially influence CD4 + T cell
activation and subsequent effector function after a
nerve injury, such as a peripheral bone marrow-derived
APC vs. a central resident microglial APC. Two
findings have developed from these studies. First,
while peripheral APCs are able to initiate CD4 + T cell
activation, they are unable to maintain activation to
promote CD4 + T cell-mediated facial motoneuron
survival. Second, while parenchymal microglia are
unable to initiate CD4 + T cell activation, they are able
to re-activate a peripherally activated CD4 + T cell to
mediate facial motoneuron survival, given that the T
cell is first activated peripherally[12, 15]. Taken together,
these findings suggest that a multi-step mechanism
exists for the development of CD4 + T cell-mediated
facial motoneuron survival, and that this mechanism
involves both an initial CD4 + T cell activation step
mediated by a peripheral APC and a re-activation step
mediated by a central parenchymal microglial APC.
Thus, while perivascular microglial cells have been
implicated in APC function resulting in
neurodegeneration, data from the facial nerve injury
paradigm in chimeric mice suggest, for the first time,
that parenchymal microglial cells play a necessary role
in regulating neuroprotective effects. These data have
also documented, for the first time, the existence of a
direct role for parenchymal microglia in antigen
presentation to a CD4+ T cell in vivo[12,15].
All of the data generated thus far suggest the
following model, following a facial nerve injury and
the release of an as-yet-unknown antigen, a peripheral
APC phagocytoses/endocytoses the antigen and
presents it to a naive CD4 + T cell residing within the
draining cervical lymph node. Meanwhile, an
as-yet-unknown signal from the periphery
communicates the injury to the central microglia,
which may release chemoattractants to recruit the
peripherally activated CD4+ T cells centrally to the site
of the nerve cell body. Once in the central
compartment, the CD4 + T cells previously activated in
the periphery are re-activated by parenchymal
microglia in the CNS. To perform the motoneuron
survival function, either the re-activated CD4 + T cell,
the parenchymal microglial cell, another unidentified
cell, or all of these cells, provide a trophic contact- and/
or soluble-mediated signal that maintains motoneuron
survival[21].
Cytokine network in repair and regeneration of
facial nerve
The imbalance of cytokine network in neuropatholog⁃
ical microenviroment
Recent data have shown that cytokine network
plays a vital role in the regulation of nervous repair and
regeneration by up- and down-regulating various
parameters of immune function[22-24]. As central
regulatory cells of the immune system, T cells mediate
many of their functions via the secretion of cytokines.
The inhibition of T cell proliferation has been
associated with a down-regulation of Th1 cytokine
interferon-γ(IFN-γ) and inflammatory cytokine tumor
necrosis factor-α(TNF-α) in supernatants of the lymph
node cells, as well as a marked increase in the
production of Th2 cytokine IL-4 in the sciatic nerves.
Kunzendorf et al. suggest that generating a balance
between expression of Th1 and the Th2 type of
cytokines may be an optimal goal for inhibiting severe
autoimmune disease[25]. However, the observations also
indicate that the role of cytokines in immune regulation
and autoimmune disease is more complex than a
simple Th1-Th2 dichotomy would suggest[26]. This is a
complex process that can be influenced by the
microenvironment. The functional distinctions between
Th1 and Th2 subsets have major implications in nerve
injury and neurodegenerative diseases and may
underlie the neural destructive-protective nature of the
immune response to neural damage.
Facial nerve injury induces activation of microglia
and astrocytes and an up-regulation of
proinflammatory cytokine expression such as TNF-α
and IFN-γ within the facial nucleus[27, 28]. The Th2
lymphocyte, known to down-regulate inflammation in
the periphery[29], may promote FMN survival by
modulating the activation of glia and the
proinflammatory milieu within the facial nucleus
following nerve injury. Th2 cells secrete IL-4, IL-10
and IL-13, which have been found to down-regulate
adhesion molecules and to induce death of activated
microglia, as well as to suppress Th1 lymphocyte
proliferation[30, 31]. The putative regulatory role for Th2
lymphocytes in promoting FMN survival after facial
nerve injury may involve mediating the inflammatory
responses to maximize the beneficial components and
to mitigate ensuing destruction.
Data presented in this review paper suggest that
CD4 + T cells differentiate into both Th1 and Th2
subsets within the periphery. It is plausible to propose
that, subsequent to differentiation, Th2 cells may
migrate into the facial nucleus to mediate a
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self-regulating Th2 response, propagated by
neuropeptides, cytokines, and trophic factors; whereas
Th1 cells, which preferentially migrate towards areas
of inflammation[32], may migrate instead to the
peripheral nerve injury site.
Neurotrophins in facial nerve repair and
regeneration
Studies concentrating on the speed of axonal
regeneration in the distal part of the nerve have thus far
focused on three groups of factors - the trophic factors
insulin-like growth factor(IGF)-1, IGF2 and brain
derived neurotrophic factor(BDNF), the TGF-β
superfamily member glial-cell derived neurotrophic
factor (GDNF), and the neurokines leukaemia
inhibitory factor (LIF) and IL-6. All three groups are
implicated in the endogenous regulation of the repair
process. Application of the closely related exogenous
growth factors IGF-1 and IGF-2 enhances and
application of antibodies reduces the pinch
test-determined speed of axonal regeneration[33, 34]. The
combined overexpression of the neurokine IL-6 and its
receptor resulted in improved nerve regeneration[35],
whereas, genetic deletion of IL-6 has been shown to
lead to a 15% reduction in the morphometrically
determined speed of axonal regeneration in the crushed
facial motor nerve[36]. Similarly, a moderate effect
has also been observed using a functional, walking test
assessment following sciatic nerve crush[37]. In contrast
to this consistent but mild IL-6-mediated action in the
periphery, there is substantial controversy regarding its
effects on the CNS. Thus, deletion of IL-6 has been
shown to reduce glial scar formation and improve
central axonal sprouting in the facial motor nucleus
model[36], enhance functional recovery after spinal cord
injury [38], but eliminate the conditional injury-induced
spinal axon regeneration[39]. It has been demonstrated
that endogenous neurotrophins are key mediators of
the myelination program in the peripheral nervous
system (PNS). By elucidating the mechanism of
neurotrophin action on the myelination process, and
characterizing this previously uncharacterized
neuronal-glial interaction, new therapeutic strategies
into myelin repair and the functional recovery of
demyelinating peripheral neuropathies may be possible
[40].
In normal intact nerves, trophic factors are
produced in the target organs, and conveyed to the cell
body retrogradely. If the communication of axons with
the cell body is interrupted by injury, Schwann cells in
Wallerian degeneration produce neurotrophic factors
including neurotrophins such as NGF and BDNF.
Neurotrophins are released from the Schwann cells and
dispersed diffusely in gradient fashion around
regenerating axons. Regenerating axons extend along
the density gradient of neurotrophins to the distal
segment. Although many other trophic factors
including IGF and fibroblast growth factor (FGF) are
shown to be involved in the promotion of the
outgrowth of regenerating axons, It is thought that,
because of absence of signal peptides in the molecules,
FGF and ciliary neurotrophic factor (CNTF) are
released from the cells not by secretion but by
mechanical damage as in injury to the cells. Schwann
cells in the intact mature nerve appear to be
morphologically inert. However, following axotomy
they begin to proliferate at the early phases of
Wallerian degeneration. Such proliferative Schwann
cells are considered to produce neurotrophic factors
actively.
IL1, TNF and IFN in facial nerve repair and
regeneration
Galiano and Bohatschek explored the molecular
mechanisms associated with the induction of MHC1 in
the mouse facial motor nucleus after facial nerve
transection. Their findings implicated actions of IL6 in
the early, and IL-1 and TNF in the late microglial
responses[36, 41]. Facial axotomy models are
characterized by two distinct types of cellular
response. In the early phase, 1-4 days after facial
axotomy, the rapid molecular changes in the
axotomized neurons are followed by activation and
proliferation of microglial cells and their attachment to
the cell bodies of the injured but living neurons[5]. In
the second, much later phase, transection of the facial
nerve leads to a loss of approximately 20-40% of
the affected motoneurons[5, 21, 42], with a peak in cell
death at day 14[43]. The neuronal debris is taken up
and phagocytosed by surrounding microglia, which
transform into rounded macrophages that aggregate to
form large glial nodules. Their interaction with the
invading lymphocytes[3, 18] places the microglia into a
strategic position to present antigens. The initial phase
is associated with a strong upregulation of IL-6,
transforming growth factor 1 and the receptor for the
macrophage colony stimulating factor. The second
phase is associated with upregulation of IL-1, IFN-γ
and TNF-β[3]. Both groups of cytokines play an
important, phase-specific role during the cellular and
molecular changes in the adult mouse axotomized
facial motor nucleus: early cytokines in the first phase,
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late cytokines in the second [36, 42].
In summary, the current review shows that neural
injury in the facial nerve axotomy model leads to an
increase in MHC2 cells, an expression pattern that is
tightly controlled in the subpopulation of perivascular
macrophages. This post-traumatic increase of MHC2
cells is associated with the induction of
inflammation-associated cytokines. It is regulated by
the receptors for IFN-γ and TNF-β. The effects of
TNFR2 and IFNR1 deletions point to a complex,
counterregulatory role of these cytokines in the
immune surveillance of the injured nervous system.
Cellular and molecular signaling pathway
Transcription factor signaling pathway
In injured neurons, the prompt arrival of signals
of cellular injury and stress is followed by the
induction of transcription factors, adhesion molecules,
growth-associated proteins and structural components
required for axonal elongation. Accompanying this is
the activation of intracellular signaling molecules,
particularly molecules that control cell cycle and
differentiation, synthesis of axonal transport molecules
and cytoskeleton components, secreted growth factors
and cytokines. And there is a general increase in
energy, amino acid and lipid metabolism[44, 45].
Following activation of mitogen-associated
protein(MAP) kinase pathways, phosphorylation and
nuclear localization of a host of transcription factors
including c-jun, junD, ATF3, P311, Sox11 and signal
transducer and activator of transcription(STAT)3, as
well as decreased expression and activity of islet-1,
ATF2 and nuclear factor kappa B(NF-κB) [9, 46, 47],
contribute to the change in gene expression of the
injured neuron. In many cases, complete deletions of
these transcription factors are embryonically lethal,
limiting studies in vivo, in the adult animal. Neuronal
specific deletion of STAT3 increases neuronal cell
death after injury[48], to a degree similar with that
observed for CNTF and LIF[49], thus pointing to the role
of STAT3 as an intracellular survival-promoting factor.
The effects of transcription factors on nerve
regeneration are well characterized in the case of c-jun.
A recent study using the facial axotomy model has
shown that neuronal deletion of c-jun hinders the
expression of genes and proteins associated with
axonal regeneration, reduces the speed of target
reinnervation and functional recovery significantly, and
completely blocks central axonal sprouting[50]. This is
in keeping with previously demonstrated data[51, 52]
where deletion of jun blocked post-traumatic neuronal
cell death and leads to severe neuronal atrophy. It also
inhibits the recruitment of lymphocytes, and the
activation of neighboring microglia.
Some axonal regeneration continues in the ab-
sence of c-jun, highlighting the importance of alterna-
tive pathways and compensatory mechanisms, which
may be shared during developmental axonal out-
growth. These compensatory molecules may incorpo-
rate additional transcription factors such as STAT3 and
ATF3[53, 54].. Clarification of their role is needed to un-
derstand the signals regulating gene expression switch-
es occurring in the regenerating neuron. The contribu-
tion of various signaling cascades, which are activated
in response to neurotrophic factors in order to support
motoneuron survival, changes during development and
STAT3 becomes increasingly important under patho-
physiological conditions.
STAT4 and STAT6 are key regulation proteins
involved in the CD4 + T cell differentiation pathways
leading to Th1 and Th2 cell development, respectively.
To determine which CD4+ T cell subset mediates FMN
survival, the facial nerve axotomy paradigm has been
applied to STAT4-deficient（+／+）and STAT6-/- mice
and study data suggest that STAT6-mediated CD4 + T
cell differentiation into the Th2 subset is necessary for
FMN survival [55].
Cell death signals
Activation of the Fas death receptor leads to the
death of motoneurons in culture. Ugolini used several
mutant mice deficient for Fas signaling and made a
novel transgenic FADD-DN (FAS associated death
domain-dominant-negative) strain to investigate the
role of Fas in programmed cell death in pathological
situations. He found a novel role for Fas as a trigger of
axotomy-induced death and suggested that the Fas
pathway might be activated in pathological
degeneration of motoneurons[56]. With the exception of
TNFR2, these cell surface receptors carry a
cytoplasmic death domain that exerts a pro-apoptotic
signal through FADD. Furthermore, expression of
dominant negative form of FADD has been shown to
block the axotomy induced cell death signal due to fas
and TNFR[56]. Associated, downstream cytoplasmic cell
death signals play a key role in promoting neuronal
cell death in neonatal and immature animals that are
sensitive to axonal injury. Deletion of bax or inhibition
of caspase 3 or the whole family of caspases has been
shown to prevent cell death[57, 58], but with an enhanced
and more persistent effect for broad caspase inhibitors
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than caspase 3 alone[58]. In both cases, bax and
caspases appear to act downstream of jun
phosphorylation (jun-P) and the decrease in neuronal
metabolism, suggesting a sequence of events beginning
with jun-P, leading to atrophy and activation of bax,
and ending with the initiation of the caspase cascade.
3 Cell adhesion molecules signaling recognition
Functional studies in vivo have thus far centered
on the role of laminin, its alpha7 beta1 integrin
receptor and galectin. Deletion of the gene encoding
alpha7 integrin subunit results in a severe,
approximately 40% reduction in the speed of motor
axon regeneration following facial nerve axotomy and
a strong delay in the reinnervation of its peripheral
target[59]. Neuronal jun-deficient mice do not show an
up-regulation of alpha7 after injury, which appears to
contribute to the very poor regenerative response
seen in these animals [50]. The absence of laminin,
the primary ligand for the alpha7 beta1 integrin, leads
to similar but more marked and lasting effects.
Alpha7-deficient mice show immense up-regulation of
the beta1 integrin following injury, which corresponds
with a significant increase in central axonal sprouting
[60] and may imply compensatory mechanisms
involving other, closely related alpha subunits. In
keeping with their trimeric and multimodal structure,
various laminins can act as ligands for a plethora of
different receptors, including the integrins, gicerin /
CD146, the 67 kDa laminin-receptor,
alphadystroglycan, and b-1, 4-galactosyltransferase [61,
62]. Application of exogenous galectin-1 has been
shown to promote the speed of neurite outgrowth,
whereas removal of endogenous galectin with antibody
neutralization or through gene deletion decreases it [63].
Galectin-1, in its oxidized form, also stimulates the
migration of Schwann cells from the proximal and
distal stumps, assisting in the formation of cellular
bridges permitting axonal growth into the distal part of
the injured nerve.
Summary and future directions
In conclusion, investigations on microglial
activation and recruitment, T cell behavior, cytokine
networks and immunological cellular and molecular
signaling pathways are the key research fields in
understanding immunobiology of facial nerve repair
and regeneration. Manipulation of these events may
provide opportunities to make immune interventions
practicable and facilitate their transition from the
laboratory to the clinic. The key incidents of nerve
repair and regeneration, including microenvironmental
changes in the injuried nerve cells and axon,
aggregation of various kinds of immune cells and
expressions of a variety of molecules in a dynamic
equilibrium, impenetrate the entire nerve injury repair
process. The concept of "immune microenvironment
for facial nerve repair and regeneration" mainly
concernes with the dynamic interaction between
expression/regulation networks and various immune
cells/ molecules after the nerve injury, which maintains
a favorable immune microenvironment for nerve repair
and regenration. Activated T cells selectively recruit
immune cells (e.g., monocytes) and cytokines (e.g.,
neurotrophic factors), through mechanisms involving T
cell-axon and neuron-Schwann cell/glial cell
interactions, and regulate proliferation of Schwann
cells and their support for the axons[64]. Many questions
remain in facial nerve injury research, regarding
activation and recruitment of monocytes and/or
macrophages; mechanisms of communication and
interactions between T cells, neuronal axons, Schwann
cells and glial cells; growth factors and signal
pathways important in activation and recruitment of T
cells and the MC/MP system; and molecular
mechanisms of the action of specific T cells on FMN
survival, to name a few. Further research will help
answer these questions and enable us to deepen our
understanding of the complex processes involved in
facial nerve repair and regeneration.
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